Works by Gregorevic, Paul


Results: 72
    1
    2
    3
    4
    5
    6
    7
    8
    9

    The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.

    Published in:
    Journal of Cell Biology, 2013, v. 203, n. 2, p. 345, doi. 10.1083/jcb.201211134
    By:
    • Winbanks, Catherine E.;
    • Chen, Justin L.;
    • Hongwei Qian;
    • Yingying Liu;
    • Bernardo, Bianca C.;
    • Beyer, Claudia;
    • Watt, Kevin I.;
    • Thomson, Rachel E.;
    • Connor, Timothy;
    • Turner, Bradley J.;
    • McMullen, Julie R.;
    • Larsson, Lars;
    • McGee, Sean L.;
    • Harrison, Craig A.;
    • Gregorevic, Paul
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.

    Published in:
    FASEB Journal, 2014, v. 28, n. 12, p. 5097, doi. 10.1096/fj.14-253856
    By:
    • Bernardo, Bianca C.;
    • Nguyen, Sally S.;
    • Winbanks, Catherine E.;
    • Xiao-Ming Gao;
    • Boey, Esther J. H.;
    • Yow Keat Tham;
    • Kiriazis, Helen;
    • Ooi, Jenny Y. Y.;
    • Porrello, Enzo R.;
    • Igoor, Sindhu;
    • Thomas, Colleen J.;
    • Gregorevic, Paul;
    • Lin, Ruby C. Y.;
    • Xiao-Jun Du;
    • McMullen, Julie R.
    Publication type:
    Article
    24

    Elevated expression of activins promotes muscle wasting and cachexia.

    Published in:
    FASEB Journal, 2014, v. 28, n. 4, p. 1711, doi. 10.1096/fj.13-245894
    By:
    • Chen, Justin L.;
    • Walton, Kelly L.;
    • Winbanks, Catherine E.;
    • Murphy, Kate T.;
    • Thomson, Rachel E.;
    • Makanji, Yogeshwar;
    • Hongwei Qian;
    • Lynch, Gordon S.;
    • Harrison, Craig A.;
    • Gregorevic, Paul
    Publication type:
    Article
    25

    Mechanisms of chemotherapy‐induced muscle wasting in mice with cancer cachexia.

    Published in:
    JCSM Rapid Communications, 2022, v. 5, n. 1, p. 102, doi. 10.1002/rco2.50
    By:
    • Murphy, Kate T.;
    • Swiderski, Kristy;
    • Ryall, James G.;
    • Davey, Jonathan R.;
    • Qian, Hongwei;
    • Lamon, Séverine;
    • Foletta, Victoria C.;
    • Trieu, Jennifer;
    • Chee, Annabel;
    • Read, Suzannah J.;
    • Naim, Timur;
    • Gregorevic, Paul;
    • Lynch, Gordon S.
    Publication type:
    Article
    26

    Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.

    Published in:
    Human Molecular Genetics, 2014, v. 23, n. 25, p. 6697, doi. 10.1093/hmg/ddu388
    By:
    • Swiderski, Kristy;
    • Shaffer, Scott A.;
    • Gallis, Byron;
    • Odom, Guy L.;
    • Arnett, Andrea L.;
    • Scott Edgar, J.;
    • Baum, Dale M.;
    • Chee, Annabel;
    • Naim, Timur;
    • Gregorevic, Paul;
    • Murphy, Kate T.;
    • Moody, James;
    • Goodlett, David R.;
    • Lynch, Gordon S.;
    • Chamberlain, Jeffrey S.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33

    TMEPAI/PMEPA1 Is a Positive Regulator of Skeletal Muscle Mass.

    Published in:
    Frontiers in Physiology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphys.2020.560225
    By:
    • Hagg, Adam;
    • Kharoud, Swati;
    • Goodchild, Georgia;
    • Goodman, Craig A.;
    • Chen, Justin L.;
    • Thomson, Rachel E.;
    • Qian, Hongwei;
    • Gregorevic, Paul;
    • Harrison, Craig A.;
    • Walton, Kelly L.
    Publication type:
    Article
    34
    35

    Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.

    Published in:
    Human Molecular Genetics, 2012, v. 21, n. 25, p. 1, doi. 10.1093/hmg/ddu388
    By:
    • Swiderski, Kristy;
    • Shaffer, Scott A.;
    • Gallis, Byron;
    • Odom, Guy L.;
    • Arnett, Andrea L.;
    • Edgar, J. Scott;
    • Baum, Dale M.;
    • Chee, Annabel;
    • Naim, Timur;
    • Gregorevic, Paul;
    • Murphy, Kate T.;
    • Moody, James;
    • Goodlett, David R.;
    • Lynch, Gordon S.;
    • Chamberlain, Jeffrey S.
    Publication type:
    Article
    36
    37
    38

    Development of Novel Activin-Targeted Therapeutics.

    Published in:
    Molecular Therapy, 2015, v. 23, n. 3, p. 434, doi. 10.1038/mt.2014.221
    By:
    • Chen, Justin L;
    • Walton, Kelly L;
    • Al-Musawi, Sara L;
    • Kelly, Emily K;
    • Qian, Hongwei;
    • La, Mylinh;
    • Lu, Louis;
    • Lovrecz, George;
    • Ziemann, Mark;
    • Lazarus, Ross;
    • El-Osta, Assam;
    • Gregorevic, Paul;
    • Harrison, Craig A
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50